Sepsis Guidelines Improve Patient Care in ER

Share this content:
Sepsis Guidelines Improve Patient Care in ER
Sepsis Guidelines Improve Patient Care in ER

THURSDAY, Jan. 19, 2017 (HealthDay News) -- Implementation of sepsis guidelines improves early assessment, recognition, and management of patients presenting to an emergency department with sepsis, according to a study published online Jan. 10 in the Journal of Clinical Nursing.

Bernadine Romero, from St. George Hospital in Kogarah, Australia, and colleagues assessed the number of patients presenting with sepsis before and after implementation of guidelines in emergency departments to improve patient outcomes. They conducted a 12-month pre-post retrospective randomized medical record audit of adult patients diagnosed with sepsis.

The researchers found that 86.6 and 100 percent of the pre- and post-groups received intravenous antibiotics. After implementation of the guidelines there was a statistically significant 230-minute reduction in time to antibiotics. The post-implementation group, which included 165 patients, received more urgent triage categories (49.1 percent), had a 758 minute decrease in the average time to second liter of intravenous fluids, and experienced improvement in lactate collection (67.9 percent); these differences were all statistically significant.

"The findings highlight the impact guidelines can have on clinician decision making and behavior that support best practice and positive patient outcomes," the authors write. "The sepsis guidelines improved the early assessment, recognition, and management of patients presenting with sepsis in one tertiary referral emergency department."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Single-Payer Health System Bill Moves Forward in California

Single-Payer Health System Bill Moves Forward in California

Not yet clear where money for the single-payer system would come from

Regorafenib Approved for Hepatocellular Carcinoma

Regorafenib Approved for Hepatocellular Carcinoma

It is the first approved treatment for HCC in almost a decade

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Rates of worsening low in patients receiving aflibercept, bevacizumab, or ranibizumab

is free, fast, and customized just for you!

Already a member?

Sign In Now »